profit from every $100 of sales.
$0$100
Ardent Health
$18.19+1.45% today
+101.9% in 1 year
1-year low $7.831-year high $18.19
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $18.88 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Ardent Health sold, what it kept, and what it did with the cash.
Sales went from $5.13 billion in 2022 to $6.32 billion in 2025, with $136 million of profit last year.
SalesProfit
Ardent Health vs. similar companies
Ardent Health grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Ardent Health | 18.9× · Fair price | ||
 HCA Healthcare | 15.6× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.5× · Fair price | ||
 IHH Healthcare Berhad | 33.4× · Expensive | ||
 Rede D'Or São Luiz | 15.9× · Fair price |
AI analysis
An AI analyst reads Ardent Health's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 5,130 | 5,409 | 5,966 | 6,324 | |
| 1,763 | 2,032 | 2,398 | 2,584 | |
| 217 | 224 | 406 | 326 | |
| 532 | 367 | 575 | 497 | |
| 189 | 54 | 210 | 136 | |
| 1.34 | 0.38 | 1.58 | 0.96 | |
| 34.4% | 37.6% | 40.2% | 40.9% | |
| 4.2% | 4.1% | 6.8% | 5.1% | |
| 3.7% | 1.0% | 3.5% | 2.1% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 4,479 | 4,732 | 4,956 | 5,290 |
| Cash | 456 | 438 | 557 | 710 |
| Total debt | 2,388 | 2,397 | 2,282 | 2,318 |
| Total liabilities | 3,429 | 3,649 | 3,434 | 3,605 |
| 0 | 0 | 0 | 0 | |
| 141 | 141 | 133 | 141 | |
| 13.0% | 7.4% | 14.8% | 11.6% | |
| – | – | – | – |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -38 | 222 | 315 | 471 | |
| 151 | 137 | 188 | 212 | |
| -189 | 84 | 128 | 259 | |
| Dividends paid | 175 | 0 | 0 | – |
| – | – | – | – | |
| 1 | 1 | 18 | 39 |
Valuation
- 18.9×
- 15.9×
- –
- 2.0×
- 0.4×
- 9.9×
- 8.4×
- 10.1%
- 5.3%
- 0.0%
Profitability
- 40.9%
- 5.1%
- 2.1%
- 7.8%
- 7.7%
- 9.7%
- 9.1%
- 2.6%
- 13.4%
- –
Growth
- +7.2%
- −10.5%
- +102.8%
- –
- +0.1%
Financial health
- 3.2×
- 1.80
- 23.1%
- 6.2×
- 1.97
- 2.00
- 1.22
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 40%of 958
Bottom 37%of 889
Top 32%of 601
Bottom 38%of 890
Top 8%of 987
What analysts expect
- Average price target
- $13.33
- Range
- $12.00 – $16.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 5, 2026 | 0.28 | 0.18 | +55.6% |
| Mar 4, 2026 | 0.32 | 0.35 | −8.0% |
| Nov 12, 2025 | 0.52 | 0.42 | +22.6% |
| Aug 5, 2025 | 0.52 | 0.30 | +73.3% |
| May 6, 2025 | 0.29 | 0.21 | +38.1% |
| Feb 26, 2025 | 0.81 | 0.50 | +62.0% |
| Nov 6, 2024 | 0.17 | 0.30 | −43.3% |
| Aug 14, 2024 | 0.34 | 0.30 | +13.3% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
49No pass
Benjamin Graham
59No pass
Philip Fisher
40No pass
Peter Lynch
17No pass
Joel Greenblatt
38No pass
Charlie Munger
33No pass
Terry Smith
39No pass
Questions about Ardent Health
Is Ardent Health a good stock to buy?
A business with weak numbers at a fair price. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Ardent Health AI analysis
What does Ardent Health do?
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. It is in Medical Care Facilities.
Does Ardent Health pay a dividend?
No. Ardent Health does not pay a dividend at the moment.
Is Ardent Health stock halal?
No. Ardent Health does not pass our halal screen: its debt is 90% of its market value, at or above the 33% limit. How we check
How has Ardent Health stock done over the past year?
Up 101.9% over the past twelve months, to $18.19. It traded between $7.83 and $18.19, close to its high.
Who are Ardent Health's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with Ardent Health's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.